866 related articles for article (PubMed ID: 22707395)
1. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
2. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
3. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
[TBL] [Abstract][Full Text] [Related]
5. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
[TBL] [Abstract][Full Text] [Related]
7. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
9. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.
Bedossa P;
Hepatology; 2014 Aug; 60(2):565-75. PubMed ID: 24753132
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
12. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
[TBL] [Abstract][Full Text] [Related]
13. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
14. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Campos GM; Bambha K; Vittinghoff E; Rabl C; Posselt AM; Ciovica R; Tiwari U; Ferrel L; Pabst M; Bass NM; Merriman RB
Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
Reha JL; Lee S; Hofmann LJ
Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.
Francque SM; Verrijken A; Mertens I; Hubens G; Van Marck E; Pelckmans P; Michielsen P; Van Gaal L
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457
[TBL] [Abstract][Full Text] [Related]
18. A modification of the Brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease.
Merat S; Khadem-Sameni F; Nouraie M; Derakhshan MH; Tavangar SM; Mossaffa S; Malekzadeh R; Sotoudeh M
Arch Iran Med; 2010 Jan; 13(1):38-44. PubMed ID: 20039768
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
20. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
Chisholm J; Seki Y; Toouli J; Stahl J; Collins J; Kow L
Surg Obes Relat Dis; 2012; 8(4):416-22. PubMed ID: 21865094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]